Guardant HealthvsUnitedHealth

GH and UNH stock compared: price, dividend, valuation and results, from SEC filings.

GH

Guardant Health, Inc.

$145.59

Value $19.1B

+0.31%
GH's page

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

Guardant Health (GH) has a market value of $19.1B and UnitedHealth (UNH) $300B. Over the last year, with dividends, GH moved +52.3% and UNH +8.2%. Dividend yield: GH none, UNH 2.74%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    GH$19.1B

    UNH$300B

    UNH is 16 times GH

  • Revenue, 12 months

    GH$1.3B

    UNH$450B

    UNH is 352 times GH

  • Net income, 12 months

    GH-$485M

    UNH$15.9B

  • Operating margin

    GH-39.4%

    UNH5.3%

    44.7 points apart

  • ROIC

    GH-33.2%

    UNH11.3%

    44.5 points apart

  • P/E

    GH–

    UNH18.9

  • Dividend yield

    GH0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    GH+45.7%

    UNH-19.5%

    65.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

GH+45.7%

UNH-19.5%

5010015020222023202420252026
Returns by period
PeriodGHWith dividendsUNHWith dividends
1 year since November 18, 2025+52.3%Price +52.3%+8.2%Price +5.4%
3 years since November 17, 2023+525.4%+84.2% a yearPrice +525.4%-34.4%-13.1% a yearPrice -38.4%
5 years since November 18, 2021+45.7%+7.8% a yearPrice +45.7%-19.5%-4.2% a yearPrice -26.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

GHGuardant HealthUNHUnitedHealth

Valuation

GHUNH
Valuation
Price$145.59$330.48
Market value$19.1B$300B
Enterprise value (EV)$19.6B$346B
P/E–18.9
P/E, 5-year median–25.0
P/B–2.9
EV/EBIT–14.5
Free cash flow yield–7.6%

Results and growth

GHUNH
Results and growth
Revenue, 12 months$1.3B$450B
Net income, 12 months-$485M$15.9B
Free cash flow, 12 months-$232M$22.8B
Earnings per share, 12 months-$3.68$17.52
Revenue growth, year on year32.9%11.8%
Revenue growth a year, past+27.9%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

GHUNH
Margins and returns on capital
Gross margin65.2%88.3%
Operating margin-39.4%5.3%
Net margin-37.9%3.5%
ROIC-33.2%11.3%
ROE–15.5%

Balance sheet

GHUNH
Balance sheet
Cash$1.0B$28.5B
Total debt$1.7B$74.3B
Net debt / EBITDA–1.6
Interest cover-96.6×6.2×

Dividends and buybacks

GHUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield0.2%1.8%
Shareholder yield0.2%4.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: GH or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Guardant Health or UnitedHealth?

By market value, UnitedHealth ($300B) is about 15.7 times Guardant Health ($19.1B), at today's prices.

How did GH and UNH stock do over the last 5 years?

Since November 18, 2021, GH's price moved +45.7% and UNH's -26.5%. With dividends: GH +45.7% (+7.8% a year), UNH -19.5% (-4.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, GH or UNH?

The dividend yield at today's price is none for Guardant Health and 2.74% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, Guardant Health or UnitedHealth?

Over the last twelve months, the net margin was -37.9% for Guardant Health and 3.5% for UnitedHealth, and the operating margin -39.4% and 5.3%. Revenue was $1.3B and $450B.

Which is the better investment, Guardant Health or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.